Skip Navigation

Cardiovascular Research 1997 34(2):289-298; doi:10.1016/S0008-6363(97)00022-9
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kline, J. A
Right arrow Articles by Watts, J. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kline, J. A
Right arrow Articles by Watts, J. A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines

Jeffrey A Kline*, Richard M Raymond, Elena D. Leonova, Thomas C Williams and John A Watts

Department of Emergency Medicine, Carolinas Medical Center, Charlotte NC 28232, USA

* Corresponding author. Tel. +1 704 355-7092; Fax +1 704 355-7047.

Objectives: This study was undertaken to examine in-situ heart function and metabolism during insulin treatment of verapamil-induced cardiogenic shock in awake canines. Methods: Twenty mongrel canines were instrumented to monitor myocardial substrate uptakes (glucose, lactate, free fatty acids, oxygen [MVO2]), as well as left ventricular (LV) end-systolic elastance (Emax), LV efficiency (LV minute work/MVO2), and Tau. Shock was induced by graded intraportal verapamil infusion followed by randomized assignment to one of 4 treatment groups: saline control (3.0 ml/kg/min, n=5), epinephrine (5 µg/kg/min, n=5), glucagon (10 µg/kg/min, n=5) or insulin (1000 mU/min, n=5) with dextrose to clamp arterial [glucose] ±10% of basal concentrations. Results: Insulin treatment significantly increased Emax (34±3 vs. 17±3 mmHg/mm, saline control), and shortened Tau (9±3 ms) compared to saline control (42±5 ms), epinephrine (20±4 ms) and glucagon (35±8 ms). With insulin treatment, mechanical efficiency increased to 20 097±2070 vs. 12 424±1615 mmHg·mm/ml O2/100 g in controls. Simultaneously, insulin increased myocardial lactate uptake (35±2 vs. 17±4 µmol/min/100 g, saline control), but did not increase glucose uptake. Epinephrine and glucagon decreased mechanical efficiency compared to saline controls, coincident with increased myocardial fatty acid consumption, but without increasing lactate uptake. One dog died early with glucagon treatment before the first death in the saline-treated group. Conclusions: Insulin improves systolic and diastolic heart function during aerobic shock and accelerates in-vivo myocardial lactate oxidation.

KEYWORDS Metabolism; Insulin; Glucagon; Epinephrine; Verapamil; Shock; Contractility; Dog, anesthetized


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J Crit CareHome page
N. P. Patel, M. E. Pugh, S. Goldberg, and G. Eiger
Hyperinsulinemic Euglycemia Therapy for Verapamil Poisoning: A Review
Am. J. Crit. Care., September 1, 2007; 16(5): 498 - 503.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
G. Shepherd
Treatment of poisoning caused by {beta}-adrenergic and calcium-channel blockers.
Am. J. Health Syst. Pharm., October 1, 2006; 63(19): 1828 - 1835.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
G. Shepherd and W. Klein-Schwartz
High-Dose Insulin Therapy for Calcium-Channel Blocker Overdose
Ann. Pharmacother., May 1, 2005; 39(5): 923 - 930.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. Chu, R. Y. Wang, and N. S. Hill
Update in Clinical Toxicology
Am. J. Respir. Crit. Care Med., July 1, 2002; 166(1): 9 - 15.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.